Zhejiang Conba Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is -3.36% vs -0.67% in Jun 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 39.23% vs -12.69% in Jun 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,617.20",
          "val2": "1,673.50",
          "chgp": "-3.36%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "150.90",
          "val2": "228.20",
          "chgp": "-33.87%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.90",
          "val2": "1.70",
          "chgp": "11.76%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "79.80",
          "val2": "16.10",
          "chgp": "395.65%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "234.60",
          "val2": "168.50",
          "chgp": "39.23%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "93.30%",
          "val2": "84.30%",
          "chgp": "0.90%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -3.19% vs 12.18% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -2.42% vs 46.64% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "6,435.60",
          "val2": "6,647.80",
          "chgp": "-3.19%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "907.20",
          "val2": "1,014.00",
          "chgp": "-10.53%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "21.80",
          "val2": "37.40",
          "chgp": "-41.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "29.70",
          "val2": "-151.70",
          "chgp": "119.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "658.40",
          "val2": "674.70",
          "chgp": "-2.42%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "86.00%",
          "val2": "102.40%",
          "chgp": "-1.64%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ

Sep'25

Jun'25

Change(%)

Net Sales

1,617.20

1,673.50

-3.36%

Operating Profit (PBDIT) excl Other Income

150.90

228.20

-33.87%

Interest

1.90

1.70

11.76%

Exceptional Items

79.80

16.10

395.65%

Consolidate Net Profit

234.60

168.50

39.23%

Operating Profit Margin (Excl OI)

93.30%

84.30%

0.90%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Sep 2025 is -3.36% vs -0.67% in Jun 2025

Consolidated Net Profit

QoQ Growth in quarter ended Sep 2025 is 39.23% vs -12.69% in Jun 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

6,435.60

6,647.80

-3.19%

Operating Profit (PBDIT) excl Other Income

907.20

1,014.00

-10.53%

Interest

21.80

37.40

-41.71%

Exceptional Items

29.70

-151.70

119.58%

Consolidate Net Profit

658.40

674.70

-2.42%

Operating Profit Margin (Excl OI)

86.00%

102.40%

-1.64%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is -3.19% vs 12.18% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -2.42% vs 46.64% in Dec 2023

All Annual Results